Author： Pal Sumanta K Bergerot Paulo G Figlin Robert A
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.12, 2012-12, pp. : 1851-1859
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current status and future directions in the pharmacotherapy of epilepsy
By Loscher W.
Trends in Pharmacological Sciences, Vol. 23, Iss. 3, 2002-03 ,pp. :
Access to resources
Recommend
Anticancer Antifolates: Current Status and Future Directions
Current Pharmaceutical Design, Vol. 9, Iss. 31, 2003-12 ,pp. :
Inhibitors of the Immunoproteasome: Current Status and Future Directions
Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. :
Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
By Jhaveri Komal Ochiana Stefan O Dunphy Mark PS Gerecitano John F Corben Adriana D Peter Radu I Janjigian Yelena Y Gomes-DaGama Erica M Koren John Modi Shanu Chiosis Gabriela
Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. :
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :